Corline Biomedical AB (CLBIO) — Cash Flow Quality Index
Corline Biomedical AB (CLBIO) has a Cash Flow Quality Index of -7.82x as of September 2023. Operating cash flow of Skr-1.60 Million is below net income of Skr204.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of Corline Biomedical AB to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Corline Biomedical AB Cash Flow Quality Index (2022–2022)
Historical Cash Flow Quality Index for Corline Biomedical AB across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check CLBIO capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Corline Biomedical AB (2022–2022)
Year-by-year earnings quality comparison for Corline Biomedical AB. For live market cap and the full company financial profile, see Corline Biomedical AB (CLBIO) market capitalisation.
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -2.77x | Skr-6.45 Million | Skr2.33 Million | — |